Literature DB >> 32576007

Regulation of lncRNA-H19/miR-140-5p in cartilage matrix degradation and calcification in osteoarthritis.

Bo Yang1, Lei Xu1, Shuang Wang2.   

Abstract

BACKGROUND: To study the effect of long non-coding RNA H19/microRNA (miR)-140-5p regulatory axis on the degradation and calcification of osteoarthritis (OA) cartilage matrix.
METHODS: Twenty cases of clinical OA cartilage tissue and healthy cartilage tissue were collected. Construction of small interfering RNA vector (si-H19) and negative control (si-Control), miR-140-5p mimic and negative control mimic-NC, miR-140-5p inhibitor, and negative control inhibitor-NC transfected human chondrocytes HC-A cells. Chondrocytes were categorized into classes of si-H19, si-Control, mimic, mimic-NC, inhibitor, NC inhibitor, inhibitor + si-H19, NC inhibitor + si-H19. The expression levels of H19, miR-140-5p, alkaline phosphatase (ALP), osteocalcin (OCN), and bone sialoprotein (BSP) in cartilage tissue and chondrocytes were detected using real-time fluorescent quantitative PCR (RT-qPCR). In each group of chondrocytes, Western blotting was used to detect the levels of matrix metalloproteinase (MMP)- 1, MMP-13, and type II α1 collagen fibers (COL2A1). CCK-8 was used to detect the cell proliferation rate, and flow cytometry was used to detect the cell apoptosis rate.
RESULTS: H19 was up-regulated in OA cartilage tissue (P<0.05); Silencing H19 not only prevented chondrocyte apoptosis but also facilitated chondrocyte proliferation (both P<0.05), down-regulated MMP1 and MMP-13 expression levels (both P<0.05), and up-regulated COL2A1 expression rates (P<0.05). Also, silenced H19 inhibited the mRNA level of ALP, OCN, and BSP and ALP activity of chondrocytes (all P<0.05). There was a negative correlation between miR-140-5p and H19 in OA cartilage tissue and chondrocytes (r=0.98, P<0.001). Silenced miR-140-5p significantly reversed the inhibitory effects of silenced H19 on matrix degradation and calcification markers in chondrocytes (all P<0.05).
CONCLUSIONS: The present study showed that the H19/ miR-140-5p regulatory axis could affect the degradation and calcification of the cartilage matrix in OA cells.

Entities:  

Keywords:  Long non-coding RNA H19 (lncRNA H19); calcification; cartilage; mechanism degradation; miR-140-5p; osteoarthritis (OA)

Mesh:

Substances:

Year:  2020        PMID: 32576007     DOI: 10.21037/apm-20-929

Source DB:  PubMed          Journal:  Ann Palliat Med        ISSN: 2224-5820


  6 in total

Review 1.  The non-coding RNA interactome in joint health and disease.

Authors:  Shabana A Ali; Mandy J Peffers; Michelle J Ormseth; Igor Jurisica; Mohit Kapoor
Journal:  Nat Rev Rheumatol       Date:  2021-09-29       Impact factor: 20.543

2.  The umbilical cord mesenchymal stem cell-derived exosomal lncRNA H19 improves osteochondral activity through miR-29b-3p/FoxO3 axis.

Authors:  Litao Yan; Gejun Liu; Xing Wu
Journal:  Clin Transl Med       Date:  2021-01

Review 3.  Crosstalk Among circRNA/lncRNA, miRNA, and mRNA in Osteoarthritis.

Authors:  Hui Kong; Ming-Li Sun; Xin-An Zhang; Xue-Qiang Wang
Journal:  Front Cell Dev Biol       Date:  2021-12-15

4.  H19 Promotes Osteoblastic Transition by Acting as ceRNA of miR-140-5p in Vascular Smooth Muscle Cells.

Authors:  Feng Xu; Jia-Yu Zhong; Bei Guo; Xiao Lin; Feng Wu; Fu-Xing-Zi Li; Su-Kang Shan; Ming-Hui Zheng; Yi Wang; Qiu-Shuang Xu; Li-Min Lei; Chang-Ming Tan; Xiao-Bo Liao; Ling-Qing Yuan
Journal:  Front Cell Dev Biol       Date:  2022-02-07

5.  MiR-19b-3p Attenuates Chondrocytes Injury by Inhibiting MAPK/NF-Κb Axis via Targeting SOCS1.

Authors:  Liang Shi; Liang Duan; Dapeng Duan; Yayi Fan; Honghai Xu
Journal:  Evid Based Complement Alternat Med       Date:  2022-10-11       Impact factor: 2.650

6.  MicroRNA-140-5p represses chondrocyte pyroptosis and relieves cartilage injury in osteoarthritis by inhibiting cathepsin B/Nod-like receptor protein 3.

Authors:  Lei Zhang; Jianjun Qiu; Jixiang Shi; Shaoyang Liu; Hanlin Zou
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.